Disposition of pulse dose methylprednisolone in adult and paediatric patients with the nephrotic syndrome
Summary
The disposition of a large pulse-dose of methylprednisolone was examined in paediatric and adult patients with the nephrotic syndrome. Plasma concentrations and urinary excretion rates were measured by high performance liquid chromatography. Most of the dose was metabolized, as indicated by urinary recovery of less than 10 percent of the dose. There was only slight age-dependence of the plasma clearance and volume of distribution of the steroid, although the T1/2 and mean transit time were shorter in younger patients. The pharmacokinetic parameters of the large doses (12–20 mg/kg) were similar to low dose (0.5–1 mg/kg) data from asthmatic patients. The limited variability of the pharmacokinetics of methylprednisolone suggests that tissue sensitivity may be a more important indicator of drug dosage needs in nephrotic syndrome.
Key words
methylprednisolone nephrotic syndrome high pulse dose pharmacokinetics adults childrenPreview
Unable to display preview. Download preview PDF.
References
- 1.The big shot (Editorial) (1977) Lancet 1: 633–634Google Scholar
- 2.Cothcart EE, Scheinberg MA, Idelson BA, Courer AG (1976) Beneficial effects of Methylprednisolone “pulse” therapy in diffuse proliferative lupus nephritis. Lancet 1: 163–166Google Scholar
- 3.Jusko WJ, Rose JQ (1980) Monitoring prednisone and predniolone. Ther Drug Monitor 2: 169–176Google Scholar
- 4.Tecklenberg DL, Mullin EM, Stinson EB, Morrow AG (1973) The effects of massive doses of methylprednisolone on myocardial contractility and peripheral vascular resistance. Am Heart J 85: 216–226Google Scholar
- 5.Gugler R, Shoemar DW, Huffman DH, Cohluria JB, Azarnoff DL (1975) Pharmacokinetics of drugs in patients with the nephrotic syndrome. J Clin Invest 55: 1182–1189Google Scholar
- 6.Morselli PL (ed) (1977) Drug disposition during development. Spectrum, New YorkGoogle Scholar
- 7.Abramowicz M, Arneil GC, Barnett HL, Barron BA, Edelmann Jr CM, Gordillo PG, Greifer I, Hallman N, Kobayashi O, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A report of the International Study of Kidney Disease in Children. Lancet 1: 959–961Google Scholar
- 8.Rose JQ, Jusko WJ (1979) Corticosteroid analysis in biological fluids by high performance liquid chromatography. J Chromatogr 162: 273–280Google Scholar
- 9.Szefler SJ, Rose JQ, Ellis EF (1980) The effect of trioleandomycin on methylprednisolone elimination. J Allergy Clin Immunol 66: 447–451Google Scholar
- 10.Metzler CM, Elfring GL, McEwen AJ (1974) A package of computer programs for pharmacokinetic modeling. Biometrics 30: 562Google Scholar
- 11.Bruning JL, Kintz BL (1977) Computational handbook of statistics, 2nd ed. Scott, Foresman Co, Glenview, IL, USAGoogle Scholar
- 12.Dedrick RL (1973) Animal scale-up. J Pharmacokinet Biopharm 1: 435–461Google Scholar
- 13.Rose JQ, Nickelsen JA, Ellis EF, Middleton E, Jusko WJ (1980) Prednisolone disposition in steroid dependent asthmatic children. J Allergy Clin Immunol 67: 188–193Google Scholar
- 14.Szefler SJ, Rocci ML, Acara M, Jusko WJ (1979) Prednisolone and prednisone metabolism and excretion in the isolated perfused rat kidney. Pharmacologist 21: 184Google Scholar
- 15.Nugent CA, Ek-mes K, Tyler FH (1959) A comparative study of the metabolism of hydrocortisone and prednisolone. J Clin Endocrinol Metab 19: 526–534Google Scholar